Skip to content
Search

Latest Stories

Contractors made to pay out of pocket as NHS ‘unilaterally’ decides to treat bank holidays as normal working days for pharmacy

A London pharmacist asks how he is expected to convince his staff to work at normal rates on a bank holiday after NHS “unilaterally” told pharmacies in England to open from 2pm to 5pm on Good Friday and Easter Monday.

NHS England and NHS Improvement (NHSE&I) said that contractors were “required” to stick to these times and would be able to claim additional payment for the extra hours. However, these rates would be based on normal working days rather than bank holidays, it added.


The requirement is being made under the new National Health Service Regulations 2020 in response to the COVID-19 pandemic.

‘How is that fair’

A pharmacy owner in East London said: “We are now forced to open on Bank Holidays when our teams desperately need a rest [after more than three weeks of massive rush], and yet this has been deemed a normal working day for us.

“GPs get to consult from home, most of the population is at home and we are forced to bring in our teams to work? How is that fair?”

In its latest Covid-19 Primary Care Bulletin, the NHS said pharmacies already planning to open for longer hours should do so and those in areas where there is minimal demand – i.e. pharmacies based within large shopping malls – can seek an exemption.

The NHSE&I regional office must be notified if a pharmacy cannot open “for reasons beyond the control of the contractor.”

Unilateral decision by NHSE&I

Reacting to the announcement, the Pharmaceutical Services Negotiating Committee (PSNC) said that the decision to require all pharmacies to open has been made unilaterally by NHS&I to support GPs who will remain open on Good Friday and Easter Monday due to the pandemic.

It has argued against this requirement on the grounds that there would already be sufficient numbers of pharmacies open under the usual Bank Holiday arrangements.

“Our understanding is that between a third and a quarter of the network is open on those two days already and some local NHSE&I teams have already made additional provision for local needs,” the negotiator noted.

Simon Dukes, its chief executive, said that the negotiator was arguing for full bank holiday funding.

“Any decision to treat the Bank Holidays as normal days fails to recognise the legal responsibilities that employers have to pay enhanced rates for work on these days, and we are trying to change their minds on this,” he said.

“We have made clear to NHSE&I just how disruptive making a decision like this on less than a week’s notice is for businesses, pharmacy teams, and their own families who also rely on them. Pharmacy teams had been holding on for this break and we are concerned that there may be an increase in temporary closures now that contractors have to manage workload pressures and staff exhaustion without the Easter break,” he added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less